The Global Market for Organ and Tissue Transplantation is Projected to Reach 166.5 Thousand Transplants by 2022

Increasing Incidence of Organ Failures as a Direct Result of the Rise in Infectious Diseases & Recurrent Chronic Disorders to Drive the Organ & Tissue Transplantation Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Organ and Tissue Transplantation market. The global market for Organ and Tissue Transplantation is projected to reach 166.5 thousand transplants by 2022, driven by the growing burden of infectious and chronic diseases that end in organ failure, increasing transplant procedures performed on the elderly encouraged by improvements in surgical techniques and treatment strategies that enhance survival rates of older patients, and steady launch of new generation anti-infective and immunosuppression therapies that reduce the risk of transplant rejection.

Organ transplantation is a treatment of last resort, and the most practical and efficient treatment option, for many patients suffering with terminal or advanced stages of organ failure. An organ or tissue transplantation is a medical procedure that involves replacement of injured or diseased organs, tissues or cells with healthy organs, tissues or cells to restore normal functions of the human body. Enhanced knowledge of transplantation over the years made organ transplantation become more readily acceptable to patients and doctors, leading to steady growth in their demand. The market for organ and tissue transplantation is exhibiting sizable growth due to aging population, increasing life expectancy, availability of advanced technologies and improved anti-infective and immunosuppression regimens. In addition, continuous developments in the field of tissue typing, and organ procurement and preservation are enabling successful transplantations while sophisticated post-transplant medications and testing regimens are improving the success rate. Improvement in patient survival rate and life expectancy is also boosting the demand for post-transplant monitoring and immunosuppression products.

Market progress largely depends on supply of organs, given that organ supply is the limiting factor in the transplantation market. Transplant-worthy organs are a scarce and valuable resource, with supply falling significantly short of demand. Several patients in need of organs hence, remain on waiting lists each year. This, in turn, is encouraging the black market for organs, as well as propelling the medical tourism market, which is driving people overseas to buy organs for transplantation. Higher costs of procedures and lack of reimbursement are also hurting the progress of the market. Over the years, the medical community began focusing on optimization of resources leveraging advances in research, treatment protocols and surgical techniques; and new means of achieving these are emerging. The dynamic world of organ and tissue transplantation is witnessing continuous progress related to transplantation techniques with the potential to reduce the rejection rate and infection risk. Technological advances in lung transplantation, for instance, are helping reverse damages occurred to lungs after the donor’s death through ex vivo lung perfusion. Continuous perfusion and removal of additional fluid makes lungs donated from deceased individuals more transplant worthy.

As stated by the new market research report on Organ and Tissue Transplantation, Europe represents the largest market worldwide supported by better organ donation programs. Asia-pacific ranks as the fastest growing market with a CAGR of 7% through the analysis period led by factors such as growing population and a parallel increase in healthcare burden, improving healthcare infrastructure, growing awareness over the importance and social and moral benefits of organ donation and the ensuing rise in the number of individuals willing to donate organs on purely altruistic and egalitarian grounds; strong policy led support for development of infrastructure critical for successful deceased donor transplant programs and rise in transplant tourism in Asian countries although partially supported by organ trafficking, medical exploitation and black market organs. Kidney transplant by far is the largest and the fastest growing market segment globally. 

Major players covered in the report include Acelity L.P. Inc., CryoLife, Inc., Exactech, Inc., Folio Biosciences, LLC, Dr. Franz Kohler Chemie GmbH, Medtronic, plc., Organogenesis, Inc., Organ Recovery Systems, Organ Transport Systems and XVIVO Perfusion AB among others. 

The research report titled “Organ and Tissue Transplantation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for Organ and Tissue Transplantation in terms of number of transplants for all major geographic markets such as United States, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Organ transplantation types analyzed for the global and regional markets include Heart, Kidney, Liver, Pancreas and Lungs. Additionally, the report presents global market analysis cornea transplantation volume.  US market for transplantation is analyzed by the following organ types in volume and value basis (Heart, Kidney, Liver, Pancreas, Lung and Intestine). Additional coverage includes US tissues transplantation market by Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), Graft Type (Autologous grafts, Allografts, Other Material), and Bone Graft Application (General Orthopedics, Spinal Fusions, and Craniao/Maxillofacial). Further, the report presents historic, present and future analysis for spending on cornea transplantation in the US market. 

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.